CVS opens new center offering primary care, pharmacy in one building
The new Erie center, located at 1535 West 26th Street, has a full-service pharmacy alongside an Oak Street Health primary care center for Medicare-eligible adults in a move CVS said will help address patient care gaps.
Pet owners will soon be able to honor pets at new Rainbow Bridge Memorial Garden
Additionally, the center offers social activities in their community room for older adults and free rides to appointments to eligible patients courtesy of Oak Street Health.
The full pharmacy will remain open to the public, offering prescription filling, vaccinations, and other pharmacy services to anyone who uses CVS Pharmacy.
Tickets now available Erie Zoo's centennial Mane Event
'With the integration of Oak Street Health, we look forward to working as part of a patient's broader care team, collaborating with Oak Street Health providers to help patients manage their medications, identify potential ways to save on prescription costs, and provide recommended vaccinations and adherence support,' said Himaswetha Bharatha, PharmD, Pharmacy Manager, CVS Pharmacy.
Similar centers have also been opened in Harrisburg and Norristown, Pennsylvania.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
28 minutes ago
- Business Insider
CVS vs. UNH: Which Healthcare Stock is a Better Buy After Q2 Earnings?
CVS Health (CVS) and UnitedHealth Group (UNH), two of the largest players in the healthcare sector, recently reported their Q2 earnings, showing contrasting performances. While CVS delivered strong revenue growth and raised its full-year guidance, UnitedHealth faced challenges with declining earnings and released a cautious outlook. This article compares the two stocks to help investors decide which healthcare giant offers a better buying opportunity after the latest results. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Is CVS a Good Stock to Buy Now? CVS has shown steady performance compared to its competitors and made a strong recovery in 2025 after several challenging years. So far this year, its stock has climbed more than 45%. For Q2, the company posted results that exceeded expectations. Notably, the Health Care Benefits segment, which includes Aetna, achieved a 39% increase in adjusted operating income. In response to these positive results, CVS raised its full-year adjusted EPS guidance to a range of $6.30 to $6.40, up from the previous $6.00 to $6.20. The company is also rolling out a $2 billion, multi-year cost-saving plan, with expected 2025 savings set to fully cover rising variable costs. These strategic initiatives and financial metrics underscore CVS Health's strong position in the healthcare sector, making it an attractive option for investors seeking stability and growth. Is UNH a Good Buy Right Now? On the other hand, UnitedHealth has faced several difficulties recently. In April, it reported higher-than-expected medical costs in its Medicare division. In May, the company pulled its full-year financial forecast, and CEO Andrew Witty resigned unexpectedly for personal reasons. Earlier this month, UnitedHealth's stock hit a new 52-week low, falling 51% over the past six months. Interestingly, UnitedHealth's Q2 results added to its challenges. The company missed earnings expectations, reporting $4.08 per share compared to the $4.45 forecast. Additionally, the company issued a weaker profit guidance for the full year. This new outlook factors in the company's performance in the first half of 2025 and expected increases in medical costs for the rest of the year. Despite the challenges, UnitedHealth's steady revenue base, ongoing investments, and expectations for earnings growth in 2026 make it an attractive option for investors willing to look past short-term setbacks. However, cautious investors should monitor how the company manages cost pressures and carries out its plans going forward. Which Healthcare Stock Is a Strong Buy, According to Analysts? Using the TipRanks Stock Comparison tool, we compared these healthcare stocks. Among these companies, CVS stock has earned a Strong Buy rating from analysts, while UNH stock carries a Moderate Buy. In terms of share price appreciation, CVS's average stock price target of $81.75 offers an upside potential of 19% from current levels. In contrast, UNH's stock price forecast of $312.65 suggests a growth rate of just 1%. Conclusion Among the stocks, CVS currently stands out as the better investment option, according to analysts. It holds a stronger analyst rating, a higher projected upside, and has demonstrated solid recent performance with raised earnings guidance. While UNH remains a strong player with long-term potential, CVS's current momentum and outlook may offer a more appealing option for investors.
Miami Herald
an hour ago
- Miami Herald
CVS, Target, Walmart: Which sell Plan B and/or the abortion pill?
Costco Wholesale has decided to not sell the abortion pill mifepristone across all its U.S. pharmacy stores, citing low demand. This isn't a change in policy or Costco (COST) dropping the medicine. It has never sold mifepristone in its warehouse clubs or through its pharmacies. "Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers," Costco said. The decision comes amid campaigns against the pill by religious activist groups, including Inspire Investing and Alliance Defending Freedom. Plan B (Levonorgestrel) Purpose: Emergency contraception to prevent pregnancy after unprotected sex or contraceptive failure (e.g., condom break). When used:Before a pregnancy starts, within 72 hours (best within 24 hours) after sex. How it works: Delays or prevents ovulation (egg release). May also prevent fertilization of the egg. Does not terminate an existing pregnancy. If the fertilized egg is already implanted, Plan B has no effect. Type: High-dose progestin (hormone), similar to birth control pill hormones, just in a single larger dose. Availability: Over-the-counter, no prescription, no age limit in the U.S. The Abortion Pill (Mifepristone + Misoprostol) Purpose: To end an existing pregnancy (up to about 10–11 weeks gestation in the U.S.). When used:After pregnancy has been confirmed (positive test or clinical confirmation). How it works:Mifepristone blocks progesterone, a hormone needed to maintain pregnancy. Misoprostol causes the uterus to contract and expel the pregnancy tissue. Type: Two different medications taken in sequence - not the same as hormonal birth control. Availability: Requires a prescription in the U.S. and is regulated under the FDA's Mifepristone REMS Program (dispensed at certified pharmacies, clinics, or by mail in states where legal). CVS: Stocked in most locations, typically in the family planning aisle; billing through insurance is possible, or pay out-of-pocket and claim later. You can also order online for Commonly available either on shelves or behind the counter; curbside and drive-thru pick-up may be offered Target: Carries Plan B both in-store and online, with options for delivery or same-day in-store Available in the family planning or sexual wellness section; online ordering with pickup or delivery options is also grocery and drugstore chains: Many large grocery store pharmacies (Kroger, Albertsons) and drugstore chains carry Plan B over-the-counter near other reproductive health retail pharmacies CVS and Walgreens: These two major chains have obtained FDA certification (through the Mifepristone REMS program) to dispense mifepristone in select locations, specifically in states where such dispensing is legally permitted. The list includes over 20 states such as California, New York, Illinois, Massachusetts, Pennsylvania, and others. However, availability varies by location and state-level restrictions Costco has said its decision on the abortion pill is a business one based on demand. The company generally stays out of politics. It has a very clear policy on its website: Costco Wholesale has a long-standing policy against making contributions to any political party or candidate, federal, state or local, in all countries in which we do business. This prohibition covers not only direct contributions, but also support through organizations created under section 527 of the Internal Revenue Code, buying tickets to political fundraising events, or furnishing goods, services, or equipment for political fundraising Company also prohibits contributions for "independent expenditures": communications that expressly advocate the election or defeat of a clearly identified candidate that are not made in cooperation, consultation, or concert with, or at the request or suggestion of, a candidate, candidate's authorized committee, or a political party. Related: Costco to keep abortion pill off shelves amid conservative outcry The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Business Insider
2 hours ago
- Business Insider
Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2
Billionaire investor David Tepper increased his stake in the struggling health insurance giant, UnitedHealth (UNH), during Q2. His move mirrors Warren Buffett 's Berkshire Hathaway (BRK.B), which also revealed a new $1.57 billion stake in UNH stock. Further, Michael Burry's Scion Asset Management bought calls on 350,000 shares. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. UNH stock gained 14% on Friday as bullish bets from Top hedge funds boosted investor hopes for a rebound. According to a recent 13F filing, Tepper's Appaloosa Management LP added 2.3 million shares of UNH, bringing the total value of the stake to $764 million. This makes UNH the fund's second-largest holding after Chinese e-commerce giant Alibaba (BABA). Tepper's bet comes at a turbulent time for UnitedHealth, which is dealing with a criminal probe into Medicare billing, a CEO shakeup, and the aftermath of a massive cyberattack. UNH stock has plunged about 40% year-to-date. Tepper Shifts Strategy on China Tepper's bet on UNH aligns with his investment strategy, which involves making bold bets on companies that others are avoiding. It is similar to his earlier investment in Chinese stocks, which he began buying last year when many investors were pulling back over economic and geopolitical concerns. It must be noted that those investments paid off as China's MSCI benchmark surged 46% over the past year due to Beijing's economic stimulus efforts. However, Tepper is now taking a more cautious approach. The fund reduced its holdings in major Chinese companies amid rising trade tensions. Appaloosa cut its stake in Alibaba by over 20% and also trimmed its positions in (JD), Baidu (BIDU), and PDD Holdings (PDD). Tepper's Other Bullish Bets Apart from UNH, the investor also ramped up his stake in Nvidia (NVDA), adding 1.45 million shares for a total of 1.75 million. This 483% increase brings the position's value to over $276 million. Also, he made some notable new investments last quarter. These include tech giant Intel (INTC), with 8 million shares valued at $179.2 million, and aerospace and defense company RTX (RTX), with 585,000 shares worth $85.4 million. The third-largest new buy is health information technology and clinical research provider IQVIA Holdings (IQV), with 300,000 shares valued at $47.3 million. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, four Holds, and two Sells assigned in the last three months. At $312.65, the average UnitedHealth stock price target implies a 2.17% upside potential.
